Dr. Libin Xu received his PhD in organic chemistry from the University of Illinois at Chicago. He then underwent postdoctoral training at Vanderbilt University, where his research expanded to chemistry and biology of lipid peroxidation underlying human diseases, as well as mass spectrometry-based lipidomics.
He joined the Department of Medicinal Chemistry at the University of Washington as an Assistant Professor in 2014 and was promoted to Associate Professor in 2020. He has been a DEOHS adjunct faculty member since 2016.
Dr. Xu is a recipient of the NIH Pathway to Independence Award from NICHD in 2012 and the Young Investigator Award from the Society for Free Radical Biology and Medicine in 2011. He is also the inaugural recipient of the School of Pharmacy Faculty Innovation Fund in 2016.
The Xu lab is interested in the chemistry and biology of lipid oxidation, xenobiotic metabolism, antibiotic resistance and the impact of xenobiotics, such as the widely used disinfectants quaternary ammonium compounds, on the nervous system, kidney, liver and microbiome, as well as the development of mass spectrometry-based metabolomics, lipidomics and imaging technologies. He is involved in multiple research projects with DEOHS faculty members Zhengui Xia and Julia Yue Cui.